Literature DB >> 6808592

Evidence that prednisolone is inhibitory to the cyclooxygenase activity of human rectal mucosa.

C J Hawley.   

Abstract

The effect of prednisolone on prostaglandin (PG) synthesis by rectal biopsies in organ culture was investigated using laminary flow bioassay and radioimmunoassay (RIA) or PGE2. Prednisolone was consistently found to inhibit basal synthesis in cultures whose duration ranged from 2-40 hours. This appeared to be both time and dose dependent. The ability of biopsies homogenised at the end of culture to transform exogenous arachidonic acid into PGE2 under defined conditions was also investigated and operationally designated cyclooxygenase activity. Prior treatment with prednisolone resulted in a reduction in cyclooxygenase activity. This inhibition occurred with a longer latency and to a lesser extent than inhibition of overall basal synthesis. These results suggest that corticosteroids, in addition to their know (indirect) inhibitory action on phospholipase activity, also affect cycloooxygenase activity. The most likely mechanism are either a repression of synthesis of fresh cyclooxygenase enzyme of induction of an endogenous inhibitor of cyclooxygenase activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808592     DOI: 10.1016/0090-6980(82)90085-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

Review 1.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 2.  Prostaglandins and ulcerative colitis.

Authors:  D S Rampton; C J Hawkey
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

Review 3.  Prostaglandins and other mediators in food intolerance.

Authors:  M H Lessof; J B Anderson
Journal:  Clin Rev Allergy       Date:  1984-02

4.  Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.

Authors:  J L Masferrer; B S Zweifel; K Seibert; P Needleman
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 5.  COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?

Authors:  L M Jackson; C J Hawkey
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

6.  Gastric mucosal protection with selective inhibition of thromboxane synthesis.

Authors:  R P Walt; R T Kemp; B Filipowicz; J G Davies; N K Bhaskar; C J Hawkey
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

7.  Inhibition of prostaglandin synthetase in human rectal mucosa.

Authors:  C J Hawkey; M Lo Casto
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

8.  Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.

Authors:  G Olaison; R Sjödahl; C Tagesson
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.